Monashee Investment Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-44,000
| Closed | -$2.02M | – | 91 |
|
|
2024
Q3 | $2.02M | Sell |
44,000
-6,000
| -12% | -$276K | 0.22% | 67 |
|
|
2024
Q2 | $2.04M | Buy |
+50,000
| New | +$2.04M | 0.26% | 43 |
|
|
2021
Q4 | – | Sell |
-110,000
| Closed | -$2.71M | – | 106 |
|
|
2021
Q3 | $2.71M | Buy |
+110,000
| New | +$2.71M | 0.5% | 46 |
|
|
2020
Q3 | – | Sell |
-40,000
| Closed | -$1.13M | – | 239 |
|
|
2020
Q2 | $1.13M | Buy |
+40,000
| New | +$1.13M | 0.17% | 127 |
|